Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug DiscoveryCRO

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1354621

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1354621

Contract Research Organization Services (CROs)

PUBLISHED:
PAGES: 803 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

Description

Table of Contents

What`s New?

» Special discussions on the global economic climate and market sentiment

» Coverage on global competitiveness and key competitor percentage market shares

» Market presence analysis across multiple geographies - Strong/Active/Niche/Trivial

» Online interactive peer-to-peer collaborative bespoke updates

» Access to our digital archives and MarketGlass™ research platform

» Complimentary updates for one year

» Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

Economic Outlook

The global economic outlook is improving, and growth recovery, albeit on the lower side, is expected for this year and the next. The United States although witnessing slowing GDP growth in response to tight monetary and financial conditions, has nevertheless overcome the recession threat. Easing of headline inflation in Euro area is helping boost real incomes and is contributing to pick-up in economic activity. China is expected to see strong increases in GDP in the coming year as the pandemic threat recedes and the government sheds its zero-COVID policy. With optimistic GDP projections, India remains on-course to emerge into a US$6 trillion economy by 2030, surpassing Japan and Germany.

The upturn, however, remains fragile and a number of interlocking challenges continue to run in parallel, such as continued uncertainty around the war in Ukraine; slower than expected decline in global headline inflation; continuation of food and fuel inflation as a persistent economic problem for most developing countries; and still high retail inflation and its impact on consumer confidence and spending. Countries and their governments are showing signs of weathering these challenges, which helps lift market sentiments. As governments continue to combat inflation to get it down to more economically conformable levels by raising interest rates, new job creation will slowdown and impact economic activity. Stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced.

Although corporate investments can likely be held back by inflation worries and weaker demand, rise of new technologies will reverse partially this prevailing investment sentiment. Rise of generative AI; applied AI; industrializing machine learning; next-generation software development; Web3; cloud and edge computing; quantum technologies; electrification and renewables and climate technologies beyond electrification and renewables, will open up the global investment landscape. The technologies hold the potential to drive sizeable incremental growth and value to global GDP in the coming years. The short-term is expected to be a mixed bag of challenges and opportunities for both consumers and investors alike. There is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Contract Research Organization Services (CROs) Market to Reach $149.1 Billion by 2030

The global market for Contract Research Organization Services (CROs) estimated at US$66.1 Billion in the year 2022, is projected to reach a revised size of US$149.1 Billion by 2030, growing at a CAGR of 10.7% over the period 2022-2030. Clinical Research, one of the segments analyzed in the report, is projected to record 11.4% CAGR and reach US$76.7 Billion by the end of the analysis period. Growth in the Early Phase Development segment is estimated at 10.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $26.5 Billion, While China is Forecast to Grow at 13.3% CAGR

The Contract Research Organization Services (CROs) market in the U.S. is estimated at US$26.5 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$10.1 Billion by the year 2030 trailing a CAGR of 13.3% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 9.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 10.7% CAGR.

Select Competitors (Total 307 Featured) -

  • 360biolabs®
  • Charles River Laboratories International Inc.
  • ICON plc
  • IQVIA, Inc.
  • KCR S.A
  • Medpace Holdings, Inc.
  • Parexel International Corporation
  • PSI CRO AG
  • Syneos Health, Inc.
  • WuXi AppTec
Show more
Product Code: MCP21551

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Contract Research Outsourcing: An Introduction
    • Qualities that have to be considered while selecting a CRO
    • Global Economic Update
    • From Pandemic to War & Inflation: "Gloomy Outlook for 2023 Despite Signs of Easing Inflationary Conditions
    • Here's How Inflationary Pressures Affect the Economy
    • Here's What's Causing Inflationary Pressures in the Global Market
    • Although Past Peak in 2023, Efforts to Solve the Inflation Puzzle Should Continue
    • Although Facing a Lower Recession Risk, Global Economic Growth in 2023 to Slowdown Amid War, Inflation, Elevated Interest Rates & Marginal Easing of Inflation: World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2020 Through 2024
    • COVID-19 Impact On Contract Research Organization Services (CROs) Market
    • Sponsor and CRO Dynamics Change with the Emergence of the Pandemic
    • Capabilities Required of CROs for Meeting the Evolving Clinical Trial Landscape
    • Competition
    • M&A Activity Rampant in the CRO Market
    • M&A Activity Yields Immense Pressure on Smaller CROs
    • Contract Research Organization Services (CROs) - Global Key Competitors Percentage Market Share in 2023 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2023 (E)
    • Players Adapt & Align with Evolutionary Changes in CRO Industry
    • Global Market Prospects and Outlook
    • Global Contract Research Organization Services (CROs) Market Set for a Rapid Growth
    • Rapidly Changing & Evolving Landscape Entails Seismic Shifts for CROs
    • Stringent Regulations Fuel the Need for CROs
    • Technology Changes the Research Foot Prints of the CRO Industry
    • Market Outlook
    • Regional Market Analysis
    • Trend of Clinical Trials Outsourcing Attains Pace in North America
    • Digital Technology Facilitates Decentralized Trials
    • Key Trends in the CRO Market
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Strong Rise in Pharmaceutical Sales to Drive Demand for CRO Services
    • Global Prescription Drug Sales (In US$ Trillion) for the Years 2017, 2019, 2021, 2023 & 2025
    • Persistent Increase in Pharmaceutical R&D Bodes Well for CRO Market
    • Surge in Clinical Trials Powers Growth of CRO Industry
    • CROs to Leverage Artificial Intelligence in a Major Way to Increase Efficacy of Clinical Research
    • Pandemic Spawns Digitization Wave
    • CROs and the Emergence of New Technology: Opportunities and Challenges
    • Popularity of Wearable technology Eases Enlisting Study groups and Tracking of Patient Activity
    • Biosimulation Enhances Data Interpretation and Pre-Verification
    • CROs: From a Humble Beginning to Partners of Moment for Drug Discovery Endeavors
    • Biotechnology Firms as Valuable Options
    • CROs in Great Demand
    • CROs with Process Maturity in Demand
    • Dealing with Geopolitical Issues
    • Decentralized Clinical Trials & Flexibility
    • Issues with Hybrid Trials & Sponsor Preferences
    • CROs to Mitigate Supply Chain Glitches
    • Bio-Pharmaceutical Sector Regains Momentum Post Pandemic
    • Growing Size and Complexity of Clinical Trials Increase Biotech's Dependence on CROs
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Contract Research Organization Services (CROs) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Contract Research Organization Services (CROs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 4: World 16-Year Perspective for Contract Research Organization Services (CROs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets for Years 2014, 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Clinical Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 7: World 16-Year Perspective for Clinical Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Early Phase Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Early Phase Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 10: World 16-Year Perspective for Early Phase Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Laboratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 13: World 16-Year Perspective for Laboratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 19: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for CNS Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for CNS Disorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for CNS Disorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 28: World 16-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Metabolic Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Metabolic Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 31: World 16-Year Perspective for Metabolic Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Infectious Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 34: World 16-Year Perspective for Infectious Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 37: World 16-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 40: World 16-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 43: World 16-Year Perspective for Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Academic Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 46: World 16-Year Perspective for Academic Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America and Rest of World for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 47: USA Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 50: USA Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 52: USA 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 55: USA 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • CANADA
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 61: Canada 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 64: Canada 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • JAPAN
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 70: Japan 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 73: Japan 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • CHINA
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 74: China Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 76: China 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 79: China 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 82: China 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • EUROPE
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Contract Research Organization Services (CROs) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Contract Research Organization Services (CROs) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 91: Europe 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 94: Europe 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • FRANCE
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 95: France Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 97: France 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 98: France Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 100: France 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 103: France 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • GERMANY
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 109: Germany 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 112: Germany 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 118: Italy 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 121: Italy 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 122: UK Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 125: UK Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 127: UK 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 130: UK 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 131: Spain Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Spain Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 133: Spain 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 136: Spain 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 137: Spain Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 138: Spain Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 139: Spain 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 140: Russia Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Russia Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 142: Russia 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 145: Russia 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 146: Russia Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Russia Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 148: Russia 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Rest of Europe Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 151: Rest of Europe 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 154: Rest of Europe 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 157: Rest of Europe 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by Geographic Region - India and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 160: Asia-Pacific 16-Year Perspective for Contract Research Organization Services (CROs) by Geographic Region - Percentage Breakdown of Value Sales for India and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 163: Asia-Pacific 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 166: Asia-Pacific 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 169: Asia-Pacific 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • INDIA
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 172: India 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 175: India 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 178: India 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 185: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 186: Rest of Asia-Pacific Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 187: Rest of Asia-Pacific 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • Contract Research Organization Services (CROs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030
  • REST OF WORLD
    • TABLE 197: Rest of World Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Rest of World Historic Review for Contract Research Organization Services (CROs) by Service Type - Clinical Research, Early Phase Development, Laboratory and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 199: Rest of World 16-Year Perspective for Contract Research Organization Services (CROs) by Service Type - Percentage Breakdown of Value Sales for Clinical Research, Early Phase Development, Laboratory and Other Service Types for the Years 2014, 2023 & 2030
    • TABLE 200: Rest of World Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Rest of World Historic Review for Contract Research Organization Services (CROs) by Therapeutic Area - Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 202: Rest of World 16-Year Perspective for Contract Research Organization Services (CROs) by Therapeutic Area - Percentage Breakdown of Value Sales for Oncology, CNS Disorders, Diabetes, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases and Other Therapeutic Areas for the Years 2014, 2023 & 2030
    • TABLE 203: Rest of World Recent Past, Current & Future Analysis for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Rest of World Historic Review for Contract Research Organization Services (CROs) by End-Use - Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
    • TABLE 205: Rest of World 16-Year Perspective for Contract Research Organization Services (CROs) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Medical Device Companies and Academic Institutes for the Years 2014, 2023 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!